scispace - formally typeset
T

Terry A. McNearney

Researcher at Eli Lilly and Company

Publications -  73
Citations -  3468

Terry A. McNearney is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Single-nucleotide polymorphism & Transient receptor potential channel. The author has an hindex of 31, co-authored 71 publications receiving 3147 citations. Previous affiliations of Terry A. McNearney include University of Arizona & University of Texas Medical Branch.

Papers
More filters
Journal ArticleDOI

Systemic sclerosis in 3 US ethnic groups: A comparison of clinical, sociodemographic, serologic, and immunogenetic determinants***

TL;DR: Important sociodemographic, clinical, and serologic differences exist between whites, African Americans, and Hispanics, despite shared genetic (HLA class II) predisposing factors; the impact of these differences on prognosis remain to be determined.
Journal ArticleDOI

Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma)

TL;DR: Gastrointestinal dysmotility in systemic sclerosis (scleroderma) is prevalent in 90% of patients, increasing morbidity and in some cases mortality.
Journal ArticleDOI

Amino acid release into the knee joint : key role in nociception and inflammation

TL;DR: The release of several amino acids after induction of knee joint inflammation in rats using kaolin and carrageenan is examined to suggest the possibility that glutamate may be released by neuronal endings in the joint.